Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Cipla wins portion of state ARV tender

Posted On: 2019-02-19 11:58:07

Cipla, South Africa's third largest pharmaceutical manufacturer, announced that it has been awarded a share of the South African Government's National ARV tender for TEE (comprising tenofovir, emtricitabine and efavirenz) and TLD (a combination of tenofovir (TDF), lamivudine (3TC) and dolutegravir (DTG)). The contract is effective from 1 July 2019 and is valid for three years.

Paul Miller, CEO of Cipla South Africa, said Cipla is proud to once again partner with State to reduce treatment costs as we strive towards ensuring that people have access to quality, affordable treatment. "We are extremely proud to have won this tender as we see a future where good health is expected, not for the few but for the many," said Miller.

In his 2018 State of the Nation speech, President Cyril Ramaphosa, stated: "We will initiate an additional two million people on antiretroviral treatment by December 2020." At the time, the Department of Health reported that an estimated 4 189 0870 people were on ARVs.

South Africa's HIV programme is the biggest in the world, according to the latest data of the Human Sciences Research Council (HSRC).

Minister of Health, Dr Aaron Motsoaledi, said South Africa aligns with the United Nation's 90/90/90 strategy to curb new HIV infections. According to the United Nations, "by 2020, 90% of all people living with HIV will know their HIV status. By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression."

Cipla has a legacy of pioneering affordable ARVs to ensure access to medication for more people: in 2001, it produced the world-first three-in-one fixed combination drug, available at less than $1 per day, thereby enabling countless more patients to have access to life-saving medication.

Cipla recently launched a new triple-combination ARV treatment, Reydin, that comprises tenofovir (TDF), lamivudine (3TC) and dolutegravir (DTG), which adds to Cipla's comprehensive portfolio of HIV medication.

Cipla has a long-standing history of working closely with government through previous tenders awarded to ensure that people get access to the necessary treatment. "This successful tender, manufactured locally at our Durban facility, is again testament to Cipla's high quality product portfolio and continued commitment to excellence," said Miller.

Shares of CIPLA LTD. was last trading in BSE at Rs.541.35 as compared to the previous close of Rs. 540.4. The total number of shares traded during the day was 53786 in over 787 trades.

The stock hit an intraday high of Rs. 544.3 and intraday low of 532.5. The net turnover during the day was Rs. 29005499.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

PFC signs agreement to acquire majority stake in REC Limited

Infosys and Roland-Garros Partner for Digital Innovation

DIAL awards the Commercial Development Rights at Aerocity, Delhi to a consortium led by M/s Bharti Realty

Bosch Ltd to form JV with Prettl India Pvt Ltd

Frontline Securities Ltd board to consider buy-back on March 26, 2019

IDFC FIRST Bank Ltd has sold 8.37% stake in ARCIL

Sun TV Network Ltd appoints R Mahesh Kumar as MD

CCL Products India Ltd board to consider interim dividend on March 23, 2019

Greenlam Industries Ltd to increase capacity through brownfield expansion

Smt. Sushmita Dasgupta appointed as Government Director of Indian Oil Corporation Ltd

Promoter group entities of Greaves Cotton Ltd to merge

California Software Company Ltd to consider allotment of OCRPS to Chemoil

Adani Transmission Ltd board approves buy-back of 10,000 NCDs

ABans Enterprises Ltd to acquire Abans Jewels Pvt Ltd

HUDCO updates on medium term note programme

Gopala Polyplast Ltd withdraws QIP

Sayaji Hotels Ltd terminates lease agreement with Barbeque-Nationa

GE T&D India Ltd updates on transformer business

Karnataka Bank opens its 839th Branch at Nadugodu - Kateel

Zensar brings 'Experience Digital Returns' focused solutions to Adobe Summit 2019

Topcoder's Crowdsourced Quality as a Service for On-Demand Testing Enables Faster Speeds, Greater Work Volumes for Customers

Krypton Industries Ltd receives order of Rs. 23.10 crores

CG equipped 'Deutsche Bucht' offshore substation topside sails out

Prima Plastics Ltd's JV declares dividend

Asian Oilfield Services receives LOI from Oilmax for contract of Rs. 210 crores for 10 years

Toyota and Suzuki Agree to Start Consideration toward New Collaboration

HFS Research Ranks HGS in the Top 3 for Voice of the customer in survey of more than 300

REC Ltd approves market borrowing programme for 2019-20

Onida launches smart air conditioners ONYXS and GENIO

Alankit Ltd Board approves interim dividend of Rs. 0.20 for 2018-19

Vodafone Idea Ltd board approves terms of rights issue

SBI Life Insurance Company Ltd fixes Apr 4, 2019 as record date for interim dividend

Newgen Positioned as a Strong Performer in Digital Process Automation for Wide Deployments by Top Independent Research Firm

Colgate Palmolive India Ltd fixes Apr 8, 2019 as record date for second interim dividend

Mahindra & Mahindra Financial Services Ltd allots 5000 NCDs worth Rs. 500 crores

The launch of Wealth Qube - 2020 at Intellect User Meet, Dubai

SHARP India Ltd board meeting to approve appointment of Mr. Naoki Hatayama as MD

Indraprastha Gas Ltd announces cessation of two independent directors

SHARP India Ltd announces resignation of MD

China Telecom Global partners with Tata Communications

HCL and Xerox expand Strategic Partnership to accelerate operational Transformation

Jet Airways India Ltd grounds another 6 aircraft

Vikas WSP Ltd updates on US court litigation

Tata Steel Bsl Ltd allots NCRPS worth Rs. 6500 crore to Tata Steel Ltd

IDBI Bank Ltd approves rupee bond borrowing limit of Rs. 4000 crore

Newgen secures another Patent for its invention - Integrated and Automatic Generation of Carbon Credits

Colgate Palmolive India Ltd board to consider interim dividend on March 29, 2019

Datamatics Global Services Limited acquires additional 10% stake in Datamatics Digital Ltd

Fortis Healthcare Ltd appoints Dr Ashutosh Raghuvanshi as MD

Maruti Suzuki India Ltd introduces EECO with additional Safety features

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019